All posts by imreal

Interactive Media launches solution to provide voice and telephony access to chatbots


PhoneMyBot: telephone access for chatbots

PhoneMyBot, a cloud solution to quickly and easily provide voice and telephony access to chatbots, is live and ready for integration, at www.phonemybot.com.

Interactive Media (https://www.imnet.com), a global developer of telecommunications software, Conversational AI and customer experience applications, is announcing the immediate availability of PhoneMyBot, a cloud solution to provide voice and telephony access to chatbots everywhere.

Chatbots are revolutionizing the customer experience, greeting customers on web pages, social networks and messaging channels. The best chatbots provide a first class experience as they field most questions and solve many issues quickly and gracefully in self-service mode – without human intervention.

However, more than 50% of the interactions are voice-based, coming in from the telephone network. For the telephone channel, in many cases the customer experience is stale and outdated, relying on legacy IVR systems and touch-tone technology: press 1 for this, press 2 for that: a far cry from the parallel chatbot experience that the same company may deploy for its digital channels.

PhoneMyBot is designed to bring phone interactions to par with the digital ones, quickly and effortlessly. PhoneMyBot integrates with chatbot platforms to transform bots into omnichannel Virtual Agents, able to use the same knowledge and conversational AI engine to power all channels. When users call in, they are greeted by the voice of your bot and can have a natural conversation with it to qualify and solve their needs, just as they would on a chat channel.

PhoneMyBot takes care of the telephony, the transcription of caller’s utterances and the rendering of the bot speech towards the caller, in any language. The conversation is piloted by the bot through its easy-to-integrate API. PhoneMyBot also connects with the contact center in the back-end to forward conversations that were not solved in self-service mode to a human agent, complete of context information.

“With PhoneMyBot, Interactive Media offers the first solution on the market providing a fast, inexpensive and effective way to add the telephone channel to chatbots everywhere,” said Livio Pugliese, CEO, Interactive Media North America. “We are excited to help organizations quickly expand self-service options to voice channels in these uncertain times, when safe and meaningful communications are paramount”.

PhoneMyBot is live in the cloud at https://www.phonemybot.com and also offered in integration with Inbenta, a leader in chatbot development platforms (https://www.inbenta.com). “The integration with PhoneMyBot will help expand Inbenta’s reach into the voice-enabled, conversational intelligent applications, which are in increasingly high demand by large enterprises”, said Jordi Torras, CEO of Inbenta.

Please visit https://www.phonemybot.com to create a free trial account and start using the telephone to talk with your chatbot now.

Interactive Media is a global developer of telecommunications software, Conversational AI systems and customer experience applications. Founded in 1996 in Italy and a leading vendor of Conversational AI voice-based Virtual Agents, the company has more than 20 years of experience working with voice and data solutions for better customer interactions. For more information, visit our LinkedIn page https://www.linkedin.com/company/interactivemediaspa/, or directly https://www.imnet.com.

Contact

Debora Moura

Marketing & Communications

info@imnet.com

Share article on social media or email:

Varicose Veins Range of Severity Highlights Importance of Seeking Professional Advice Regarding Solutions, says West Medical


West Medical provides vein therapy and weight loss procedures at locations Southern California.

There’s no reason for individuals struggling with varicose veins to remain in pain and/or embarrassment as there are a variety of treatment options available.

A March 16 article on Allure reports on the different ways to treat varicose veins, which is a condition where veins become enlarged or swollen due to issues with blood circulation. The article discusses common minimally invasive treatments that are available, such as sclerotherapy or laser. West Medical, a healthcare group based in Southern California, says that while varicose veins may only be a cosmetic issue for some individuals – and that’s problem enough – it may also cause physical discomfort for others. With today’s resources and advances in medical technology, West Medical comments that there’s no reason for individuals struggling with varicose veins to remain in pain and/or embarrassment as there are a variety of treatment options available.

West Medical says that the simplest method for varicose veins is through the use of compression stockings, which are intended to improve the circulation of blood flow by adding pressure to the veins. With improved circulation, the sometimes painful condition may improve without any further treatment but the cosmetic benefit may be somewhat variable. The Orange County medical group notes that this home treatment is often useful for individuals with minor cases though, or it can at least serve as a temporary solution that may slow down the progression of the issue before medical treatment is sought. While this is an easy home remedy, the clinic notes that this treatment leaves enlarged veins intact.

West Medical says that a more effective and preferred treatment for varicose vein treatment is by targeting veins via endovenous laser treatment (EVLT). This method involves inserting a small laser fiber into the problem vein with ultrasound and allowing the laser to close the vein through the generated heat. The healthcare group notes that this technique only requires a local anesthetic and can be done in one of its offices. The office notes that the EVLT is very minimally invasive, which means less downtime needed for recovery and quicker healing.

The health group notes that because there are different kinds of varicose veins, each varying in severity, it recommends individuals who are seeking out treatment options consult with a physician for the best solution for their situation. Each individual’s case is unique, and a doctor will be able to determine which varicose vein treatment will be the most effective for each patient’s particular circumstance.

Readers who are interested to learn more about Southern California based healthcare group West Medical and their services can visit the group’s website at https://westmedical.com or call (855) 678-4778.

Share article on social media or email:

Research Team Identifies 64 FDA-Approved Drugs as Potential Treatments for COVID-19


Our research has centered around drugs that are already FDA-approved and effective in treating other viruses in order to find compounds that will not only be useful in fighting COVID-19 but also safe with minimal side effects.

CureMatch, a digital health company focusing on personalized medicine and combination therapies, today announced that Chief Science Officer and Co-Founder, Dr. Igor Tsigelny, along with Dr. Valentina Kouznesova of the San Diego Supercomputer Center and Moores Cancer Center and David Huang of the San Diego Supercomputer Center and CureMatch have jointly published a study that identifies 64 FDA-approved drugs as potential COVID-19 protease inhibitors. Included in their list are three drugs that have already shown some benefit for COVID-19 treatment, making research into the COVID-19 protease a promising path to rapidly finding drug candidates to treat patients infected with the novel coronavirus.

“The need is critical to find drugs that can be immediately used to treat patients suffering from COVID-19 worldwide,” said Dr. Tsigelny. “Our research has centered around drugs that are already FDA-approved and effective in treating other viruses in order to find compounds that will not only be useful in fighting COVID-19 but also safe with minimal side effects.”

Begun in March of 2020, the study used the recently published structure of the COVID-19 protease to develop a pharmacophore model of the protease inhibitor-binding pocket. The COVID-19 protease is a key viral protein related to the production of other viral proteins that harm the patient. The drug-candidates can be thought of like a key fitting into a lock. The COVID-19 protease inhibitor is the key and the binding pocket is the lock. An effective protease inhibitor will fit into the binding pocket, also called “docking” and block the COVID-19 protease from its function. Next, the team conducted data mining of the conformational database of FDA-approved drugs. Through this search, the team found 64 compounds that fit the binding pocket’s shape.

They then tested these 64 drugs to see which ones fit into the binding site with the lowest effort or ‘free energy’. They listed each compound organized by lowest to highest free energy value. Using the same model and process as with the 64 compounds, they also tested randomly selected compounds. The results show that the 64 chosen compounds perform better than the randomly selected compounds in terms of free energy, meaning they will likely perform better as a protease inhibitor for COVID-19 than the randomly selected compounds. Unique to the methodology of this study is the combination of the pharmacophore-based drug design and molecular docking of the possible conforming drugs.

A major benefit of this research is that all proposed drug candidates are already approved by the FDA, meaning that all 64 drugs chosen for this study have been tested for safety and proper dosage for patients. This speeds testing and development time and can potentially result in drugs approved much faster to fight COVID-19. The next step in this research will involve using a much larger database of FDA-approved drugs and available natural compounds to run the same search using the same pharmacophore/docking approach. The goal would be to run the same search strategy with the NCI database of around 250,000 compounds.

A full description of the study and results achieved can be found at https://bit.ly/CureMatch_COVID-19_research. Research teams interested in exploring this study further should reach out to Dr. Tsigelny at itsigelny@curematch.com or itsigeln@ucsd.edu.

About CureMatch

CureMatch, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients based on their molecular tumor profile. CureMatch enables oncologists to become experts in personalized medicine by providing them with actionable intelligence towards advanced cancer treatment options. Currently, the CureMatch team is using all their expertise to develop drug-candidates for COVID-19 patient treatments. To learn more visit http://www.curematch.com.

Share article on social media or email:

Mesa Science Associates and Bryn Pharma Publish Pre-Clinical Study of a New Approach to Treating Anaphylaxis


News Image

Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three (3) pre-clinical studies conducted in beagle dogs. These studies establish that epinephrine is readily absorbed when administered intranasally and that the intranasal absorption of epinephrine is not altered in the presence of congestion. In fact, the absorption of epinephrine was enhanced in the histamine-induced congestion model when compared to a non-congestion model. The pre-clinical study was managed by MSA and was conducted at MRI Global Laboratories in Kansas City, MO. The study was funded by Bryn Pharma LLC of Raleigh, NC. The study was published in Respiratory Research and is entitled Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model.

Anaphylaxis is a serious and sometimes life-threatening allergic reaction where the immune system overreacts to an allergen by releasing histamines that cause allergy symptoms. In severe cases if anaphylaxis isn’t properly treated, it can be fatal. Rates of such reactions have increased over the last 20 years and are usually treated by administering epinephrine into a muscle with an auto-injector.

The study offered an alternate route of administration for epinephrine, via the nose, reducing the anxieties that come along with auto-injector use. A device containing epinephrine for nasal administration can offer convenience with its small size by being easier to carry and is noninvasive when compared to the intramuscular injection involved with the auto-injector. Intranasal administration of epinephrine could lead to increased usage versus an auto-injector, with less hesitation for use in patients with severe allergies.

The study focused on evaluating whether changes in the nasal environment, such as congestion produced by histamines, could influence the absorption of the drug. The study compared the rate and amount of epinephrine absorbed via the nasal cavity in a canine model of congestion produced by the local administration of histamine compared to non-congestion control subjects.

This research found that epinephrine was absorbed more rapidly and in greater amounts over 90 minutes in the presence of histamine-produced congestion as compared to non-congested subjects. One of the routine effects observed with epinephrine is an increase in heart rate. The study found that heart rate increases were greater in the congestion model, which correlated with the greater absorption of epinephrine. It should be noted that during the conduct of these studies no animals were injured, and all of the study dogs were adopted into forever homes.

Michael Mesa, CEO of Mesa Science Associates, is anticipating the publication of the next two (2) studies within several months. These pre-clinical studies preceded human studies which were started in 2019 and are planned for completion over the coming summer.

In addition to the pre-clinical studies, MSA continues to provide support for Bryn Pharma nasal product development activities including device activities, identification of a contract fill and finish source, and coordination with the fill and finish source for Chemistry, Manufacturing and Controls activities. MSA also utilizes its extensive list of pharmaceutical experts to provide advice on a variety of manufacturing, quality, technical and scientific issues.

Mesa Science Associates is a pharmaceutical product development company located inside the Frederick Innovation and Technology Center Inc. (FITCI) in Frederick, MD. The mission of the company is to provide technical and scientific expertise to researchers from all aspects of the drug, drug delivery and product development community, including researchers from government, academia, as well as private entities.

For more information on Mesa Science Associates visit http://www.mesascience.com/

Share article on social media or email:

Legion Technologies Named to JMP Securities “Hot 100” List of Best Privately Held Software Companies


“We invested in Legion because its machine-learning platform and automation dramatically reduces time spent by the enterprise on workforce administration,” Sean Jacobsohn, partner at Norwest Venture Partners

Legion Technologies, the leading AI-powered workforce management platform, today announced it has been named to the “Hot 100” List of the best privately held software companies by JMP Securities, a full-service investment bank.

Now in its 10th year, the Hot 100 list identifies leading private companies that show outstanding potential, based on financial growth, products and services, quality of leadership, customers and market potential.

Founded in 2016, the Legion platform is used by customers like Philz Coffee, Barry’s Bootcamp, RaceTrac Petroleum and Cinemark for labor management.

“Legion’s cutting-edge technology and data science improves labor efficiency, reduces wasteful spend on compliance violations and automates scheduling to deliver an unprecedented ROI to our customers,” said Sanish Mondkar, CEO and Founder of Legion. “Tightly managing labor spend is now more important than ever in these unprecedented times for service industries, compounded by the COVID-19 challenges. We are excited by the opportunity to partner with our customers across many industries in delivering these results.”

“We invested in Legion because its machine-learning platform and automation dramatically reduces time spent by the enterprise on workforce administration,” said Sean Jacobsohn, an early investor in Legion and partner at Norwest Venture Partners. “As the market begins to rebound, Legion’s AI and ML-driven solution will help companies successfully navigate the road to recovery and keep costs in check.”

The addition to JMP Hot 100 List continues a wave of recent recognitions for Legion, including being named one of Business Insider’s “72 startups that will boom in 2020,” and its inclusion in Gartner’s 2019 Market Guide for Workforce Management Applications.

About Legion Technologies

Legion is reinventing how companies manage and empower their hourly workforce. By accurately forecasting demand, computing precise labor needs and staffing with the right employees at the right time based on employee skills and preferences, Legion’s autonomous, AI-powered Workforce Management platform enables companies to tightly manage labor spend while delivering great experiences for their customers and employees. Legion serves mid- to large-enterprises that manage a large hourly workforce, across a wide range of industries including retail, hospitality, healthcare, food & beverage and distribution centers. Legion is headquartered in Redwood City, CA and is backed by Norwest Venture Partners, First Round Capital, Webb Investment Network, and XYZ Ventures. To learn more, visit legion.co.

Share article on social media or email:

Osmosis.org Releases COVID-19 Music Video


News Image

‘Flatten The Curve, Raise The Line’ not only amplifies awareness around what we all need to do to ‘flatten the curve,’ but introduces a new concept: ‘raising the line,’ which means increasing the capacity of the healthcare system

Today, Osmosis.org, a health education platform empowering over 2 million current and future healthcare professionals with the best learning experience possible, released a music video. Health education companies don’t always release cheeky music videos, but when they do, it’s to help fight and prevent future pandemics.

“Flatten The Curve, Raise The Line” not only amplifies awareness around what we all need to do to “flatten the curve,” but introduces a new concept: “raising the line”, which means increasing the capacity of the healthcare system so that even as the epidemic curve rises, we’re able to appropriately care for those affected.

Osmosis.org Co-Founder and CEO Shiv Gaglani coined the term and began using the #RaisetheLine hashtag in early March, and it has since been shared and seen by 8 million people.

“We’re seeing alarming headlines about how people around the world continue to congregate despite warnings to stay home, so we thought we could help spread the message, from the point of view of healthcare professionals, with joy and positivity,” said Gaglani.

The song was written by Evan Debevec-McKenney (aka Evan Diem), a senior editor and voice over artist, and self-proclaimed Music Director at Osmosis. While it outlines the role we all have to play in overcoming COVID-19, it also points to a problem that extends beyond the pandemic: the growing shortage of doctors and nurses, and what can be done to solve it. That is at the core of what Osmosis.org is doing: making health education engaging and accessible for far more people than it is today.

For more information on how you can help stop the spread of COVID-19, visit osmosis.org/covid-19. And remember, “you can buy us some time,” as Evan would say.

About Osmosis.org

Osmosis.org is a health education platform that empowers the world’s clinicians and caregivers with the best learning experience possible. As pioneers in medical education technology, we take learning beyond textbooks and lectures by offering online educational video content that’s simple, engaging and informative. Osmosis.org has a library of over 1,500 videos covering pathology, physiology, pharmacology, and clinical reasoning complete with questions, flashcards, and notes. We are grateful to our engaged audience of more than 900,000 active learners made up of current and future health professionals, as well as a YouTube channel with 1.5 million learners worldwide.

Share article on social media or email:

KaviAR Tech Announces New Augmented Reality Travel App KaviAR Gate


KaviAR Gate is an educational and enlightening new tool that harnesses the power of augmented reality, allowing the consumer to travel through a virtual doorway to their choice of incredible destinations.

KaviAR Tech, an augmented reality-focused startup headquartered in Paris, announced its new app KaviAR Gate, the world’s first augmented reality teleportation application tool allowing one to “visit” exotic destinations right from their smartphone.

The KaviAR Gate demonstration may be viewed at https://gate.kaviar.app and downloaded at the Apple Store (iPhone here: https://apps.apple.com/fr/app/kaviar-gate-ar-portal-360/id1502873747 and Android here: https://play.google.com/store/apps/details?id=com.kaviar.gate&hl=en_US).

“KaviAR Gate is an educational and enlightening new tool that harnesses the power of augmented reality, allowing the consumer to travel through a virtual doorway to their choice of incredible destinations—from an idyllic French beach to the legendary Grand Canyon,” stated Michel Ruiz, co-founder of KaviAR Gate. “During today’s global health crisis, the temptation to step outside has never been stronger as the beautiful spring weather arrives and upcoming vacations have been cancelled. KaviAR Gate allows you the chance to discover new places, have fun with AR and take a ‘vacation’—at a time when most people could truly use one—from wherever you are, allowing your mind to relax, wander and explore.”

The newly-available KaviAR Gate app is free to download and gives one the ability to travel through a virtual doorway in their living room to breathtaking locations across the world, from stunning beaches in Madagascar, Tobago Cay and South Carolina to a casino in Las Vegas, a cathedral in Italy and the Angkor temple in Thailand, to the Andean Lagoons in Peru, the Lion’s Head and Table Mountain Peaks in South Africa, and the incredible Eiffel Tower and Seine River in Paris—and many others.

In addition to helping consumers discover new virtual destinations, the KaviAR Gate app presents a valuable marketing opportunity for tourism professionals and operators, where they can promote and highlight key tourist attractions, cities, and destinations. It is also a beneficial way for travel-industry businesses to showcase their services and offerings, harnessing the power of augmented reality to feature any travel environment.

An immersive, 360-degree experience, possible thanks to augmented reality technology, KaviAR Gate allows the consumer to become immersed in a real photo or video setting wherever they are.

“KaviAR Gate aims to introduce people not just to incredible destinations, but to the power of augmented reality,” Mr. Ruiz stated. “KaviAR envisions a future where consumers’ smartphones become an interface, a filter between the real world and the virtual world, and a source of better-quality experiences that lead to richer experiences and greater success. Since 2018, KaviAR has pioneered augmented reality technology to bring its benefits to as many people as possible.”

About KaviAR Gate

KaviAR Gate is a new augmented reality application, allowing consumers to virtually visit global destinations through a virtual “doorway”, right on their smartphones. Simply download the app, select your destination, position your doorway, and walk through the gate—and you have arrived. KaviAR Gate is a product of KaviAR Tech, an augmented reality software startup. For more information, please visit https://gate.kaviar.app.

About KaviAR Tech

Founded by Michel Ruiz, Anthony Merzouki and Wajdi Ben Rabah, KaviAR Tech is an augmented reality market software startup focusing on augmented reality content. With the use of the KaviAR application, anyone can place content in augmented reality though the screen of their smartphone. While the majority of North American and European consumers use a smartphone, augmented reality solutions have not lived up to their potential. KaviAR helps companies and brands to place the content of their choice, including images, video, a web link or 3D objects, in augmented reality—on any medium. KaviAR Tech’s technology is able to recognize any image that has been augmented using the software; there is no need for a QR code or to modify existing images. From street signs to company logos to billboards and business cards, companies can create the augmented reality experience of their choice. KaviAR envisions a future where consumers’ smartphones become an interface, a filter between the real world and the virtual world, where augmented reality both educates and inspires, transforming the world for the better. For more information, please visit https://www.kaviar.app.

Share article on social media or email:

NeilMed Commits to Its Employees and the Healthcare Community Amidst the COVID-19 Crisis


Commitment to the Healthcare Community

Thank you so much for the N95’s that you donated to the local Disease Control Unit at Public Health. We have been doing testing of household members using appropriate PPE. Thank you for your donation. Mary Miller, MSN Nursing Services Director County of Sonoma Department of Health Services

Commitment to the Healthcare Community

As a healthcare company, NeilMed Pharmaceuticals, Inc. is dedicated to providing relief to hospitals and health workers on the frontlines. Thus, NeilMed has committed a minimum of USD $250,000 to invest in items to give to the medical community as they fight COVID-19 infections. As this pandemic unfolds, NeilMed is stepping up to serve our communities during this crisis by donating a variety of equipment needed by healthcare professionals to protect themselves as well as their patients.

Using its robust manufacturing facility, NeilMed has begun to produce hand sanitizer to donate to hospitals and other relief organizations. NeilMed will manufacture 20,000 three-ounce bottles of hand sanitizer to be used by medical professionals and those in need. This volume of hand sanitizer will also protects NeilMed employees and their families and maintains the sterility of our facility.

With protective equipment in short supply worldwide, NeilMed is acquiring and donating:

1) 100,000 FDA-approved KN95 masks;

2) 100,000 surgical masks;

3) 2,000 surgical sterile gowns;

4) 10,000 face shields; and

5) 5 thermal scanners

As NeilMed continues to receive shipments of these items from its manufacturers, they will be donated to doctors, nurses and other health workers in the local Bay Area community as well as throughout the country. NeilMed has already given a significant amount of these items to health professionals and continues to form partnerships with hospitals and clinics to arrange for donations.

NeilMed will also donate its branded nasal irrigation and other products to healthcare professionals, first responders and others treating COVID-19 patients upon request. These products promote the health, hygiene and well-being of users and NeilMed is happy to provide them for those in need.

Those who are part of a nonprofit, health clinic, hospital or other organization that would benefit from partnering with NeilMed to receive these protective products and NeilMed products are encouraged to contact NeilMed for assistance. Reach out to questions@neilmed.com or by calling 1-877-477-8633.

Commitment to NeilMed Employees

As the COVID-19 pandemic continues, the well-being of NeilMed employees is of utmost importance. NeilMed would like to share with you how the company is currently providing employees with a clean, safe workplace to keep bringing consumers the healthcare products they need.

NeilMed looks after the safety and well-being of employees by taking steps to ensure that the offices and manufacturing facility are safe and healthy environments. Employees are well-trained regarding CDC and WHO guidelines concerning COVID-19. NeilMed is committed to making sure those guidelines are followed at its offices, and to showing appreciation of our employees’ hard work. Some of the measures taken include:

1. Using technology to allow the bulk of NeilMed employees to work remotely whenever possible.

2. Encouraging social distancing in the front offices by eliminating business travel, avoiding cross-traffic through office doors and staircases, creating additional office space, separating manufacturing employees from front office employees, providing phone and screen-sharing technology for intra-office communications, and digitally signing documents.

3. Creating policies conforming to CDC and WHO guidelines that require employees to maintain distance from one another, sanitize their workstations, stay home when they are sick, and other obligations. These policies are posted throughout the office, distributed to employees and communicated in frequent meetings.

4. Reducing the risk of spread of COVID-19 by taking employees’ temperatures via thermal body scanners upon arrival and departure and intermittently throughout production hours.

5. Enhancing cleaning and sanitization measures in the manufacturing facility by providing ample hand sanitizer stations, installing four extra sinks for hand-washing, and other efforts.

6. Reducing the risk of the spread of COVID-19 between manufacturing employees by providing them with masks and gloves.

7. Adding a third shift to reduce the number of employees working during each shift.

8. Modifying manufacturing lines to space employees farther away from one another.

9. Slowing machine speeds to reduce the number of employees present on the production line.

10. Rewarding employees with increased pay, bonuses and providing them with daily meals and complimentary NeilMed products. Meals are sourced from local restaurants that are struggling during this crisis.

11. In the break areas, microwave use has been eliminated, and the number of dining tables and chairs has reduced to enable employees to social distance.

12. Employees who carpool together are placed into teams to work on the same production lines together, away from other groups of employees.

13. Limiting the number of activities performed on-site by, for example, temporarily curbing marketing mailer and sample request projects.

These measures mean that ultimately, NeilMed’s valuable team can bring consumers products manufactured in a safe and clean facility. NeilMed is committed to serving its employees and loyal customers during this difficult time. NeilMed encourages you to contact questions@neilmed.com with any further inquiries you may have.

Share article on social media or email:

Maestro PMS Recognizes Hoteliers That Stand Up to CV-19 as Community Donations Cover Over 1000 Room Nights for Health Care Heroes


News Image

We are privileged and honored to be associated with these operators who are giving back to their communities. Thank you for all you are doing.

These are unprecedented times for our industry. Operators are facing business challenges beyond their control. Nevertheless, many operators and hotel companies are putting the true meaning of ‘hospitality’ into action. Hundreds of operators with dozens of brands are making their properties and facilities available for use by medical personnel and first responders. Maestro’s team is proud to be associated with many of these hoteliers who are giving back to their communities by opening their doors during this difficult time.

The Silver Hotel Group, a family owned company, is offering a safe and comfortable place to rest for front line medical staff and first responders. “Our properties have specific floors dedicated to front-line workers, with a dedicated elevator where possible, to help mitigate the community spread of Covid-19”, said Shivani Ruparell, VP of Silver Hotel Group.

Accent Inns opened its doors to offer rooms at cost for front-line essential service workers, “We considered closing our doors because our reservations office was only taking cancellations and clearly travel was drying up,” said Trina Notman, VP of Marketing & Communications at Accent Inns. “Then, a nurse who was desperate for a place for her colleagues to self-isolate called us for help because some of her colleagues had taken to sleeping in their cars to avoid risking passing the virus on to their families. We quickly created an at cost room rate for front-line essential service workers, and our PR agency, Beattie Tartan, got the word out that Accent Inns was ready to help.” Accent Inns was surprised when people and organizations in its communities offered to pay for the rooms. Accent Inns then partnered with the United Way Greater Victoria and created the Hotels for Frontline Workers Fund. “A wonderful surprise was that we were flooded with calls from people that actually wanted to pay for a night’s stay for these workers. To date we have sold over 1,000 room nights covered by community donations through this program. It is tremendous to be able to tell these workers that their stay is covered.”

Another example is AHLA’s Hospitality for Hope Initiative that was created to boost collaboration between the hotel industry and local, state and federal governments to help employees, communities, and the industry during this unprecedented health crisis. AHLA recently announced a partnership with its partner state associations to support communities across the country by connecting hotels with the health community to find housing and support for medical staff and first responders. Over 16,000 hotels have signed up for AHLA’s Hospitality for Hope Initiative.

The Center for Health Design has assembled tools and resources to assist healthcare providers with current infection control needs and to inform future project planning. It created a website forum that lists hundreds of properties that are willing to share their resources with hospitals and other care providers. The site lists hotels and others with multi-unit or high-occupancy residential facilities and indicates their capacity and willingness to consider these urgent needs.

“Maestro’s entire team recognizes that these outstanding hospitality organizations and their people are working hard and investing time and money during this difficult time,” said Maestro PMS President Warren Dehan. “We are privileged and honored to be associated with these operators who are giving back to their communities. Thank you for all you are doing.”

About Maestro PMS

Maestro is the preferred cloud and on-premises PMS solution for independent hotels, luxury resorts, conference centers, vacation rentals, and multi-property groups. Maestro’s PCI certified and EMV ready enterprise system offers 20+ integrated modules on a single database including web and mobile apps to increase profitability, drive direct bookings, centralize operations, and enable operators to engage guests with a personalized experience. For over 40 years Maestro’s Diamond Plus Service has provided unparalleled 24/7 North American based support and education services to keep hospitality groups operational and productive. Click here for more information on Maestro. Click here to get your free PMS Buying guide.

The Maestro Property Management System delivers flexible and scalable deployment options with an identical full-featured web browser or windows solution available in the cloud or on premise. Maestro’s revenue-generating hotel management software tools and services increase profitability, drive direct bookings, centralize operations and provide personalized and mobile guest service tools to enhance the guest experience.

Share article on social media or email:

Vaughn College Launches Efforts to Support New York City High School Students During the COVID-19 Pandemic


News Image

We also know it’s a particularly hard time for high school seniors, so we are providing supplemental support service to help students with their studies now, and ease their transition into college when campuses reopen.

Vaughn College of Aeronautics and Technology was in a prime position to move all of its courses online in March in an expedited manner having experience with distance learning for its degree programs. Upon hearing of the severity of the outbreak and the Governor’s orders, the College ramped up its efforts to train all faculty on its online teaching platform, D2L, and Zoom technology to offer synchronous and asynchronous learning. Vaughn’s staff was also trained on the Zoom platform to provide support to current, prospective and the New York City Department of Education high school students requiring assistance.

“We are working very hard to support all those within the Vaughn community and New York City area,” said Dr. Sharon B. DeVivo, president of Vaughn College. “Queens, where Vaughn is located, and the entire New York metro area have been particularly hard hit and we recognize the difficulty for students and their families as they try to continue their education from home. We also know it’s a particularly hard time for high school seniors, so we are providing supplemental support service to help students with their studies now, and ease their transition into college when campuses reopen.”

In order to provide academic support during this challenging time, Vaughn College is offering the following online services to high school students through the office of admissions, academic success center, and Vaughn’s pre-college enrichment programs designed for middle and high school students who want to get a head start on preparing for their college education.


  • Free tutoring with Vaughn’s regularly scheduled tutors
  • A free, three-credit Freshman Year Initiative summer course for students who register, designed to prepare them to be college-ready, through an online format. This course may be transferable.
  • Vaughn’s Science and Technology Entry Program (STEP) Saturday Academy has moved to an online format to support its participants
  • A professional weekday tutor in flight is available online for STEP students
  • An online format for the federally-funded Upward Bound Saturday Academy pre-college enrichment program
  • The purchase of grant-supported laptops for instructors and students to help with the adjustment to the online environment
  • Extra weekday online tutoring through Upward Bound to fill the gaps in students’ academics caused by educational disruption
  • Application fees will be waived for new applications
  • Unofficial documents will now be considered for admissions decisions
  • For those who wish to register prior to June, the tuition deposit will be waived until June 1
  • Vaughn typically requires all bachelor of science applicants to submit SAT or ACT test scores. In lieu of those scores, applicants will take an assessment test administered by Vaughn to determine their program acceptance and course placement.

For more information on any of these programs visit Vaughn.edu/admissions or Vaughn.edu/coronavirus.

VAUGHN COLLEGE: Founded in 1932, Vaughn College is a private, nonprofit four-year college that enrolls more than 1,600 students in master’s, bachelor’s and associate degree programs in engineering, technology, management and aviation on its main campus in New York City and online. The student-faculty ratio of 15 to 1 ensures a highly personalized learning environment. Ninety-nine percent of Vaughn College graduates, eighty three percent in their field of study, are placed in professional positions or choose to continue their education within one year of graduation. They work in 20 countries and all 50 states. The institution serves many first-generation college students and is recognized by the US Department of Education as a Hispanic-Serving Institution.

Share article on social media or email: